Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $24.2 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.